Abstract:PURPOSETo investigate the possibility of using motexafin gadolinium (MGd)-enhanced molecular magnetic resonance (MR) imaging and optical imaging to identify the true margins of gliomas.MATERIALS AND METHODSThe animal protocol was approved by the institutional animal care and use committee. Thirty-six Sprague-Dawley rats with gliomas were randomized into six groups of six rats. Five groups were euthanized 15, 30, 60, 120, and 240 minutes after intravenous administration of 6 mg/kg of MGd, while one group received only saline solution as a control group. After craniotomy, optical imaging and T1-weighted MR imaging were performed to identify the tumor margins. One-way analysis of variance was used to compare optical photon intensity and MR imaging signal-to-noise ratios. Histologic analysis was performed to confirm the intracellular uptake of MGd by tumor cells and to correlate the tumor margins delineated on both optical and MR images.RESULTSBoth optical imaging and T1-weighted MR imaging showed tumor margins. The highest optical photon intensity (2.6 × 10(8) photons per second per mm(2) ± 2.3 × 10(7); analysis of variance, P < .001) and MR signal-to-noise ratio (77.61 ± 2.52; analysis of variance, P = .006) were reached at 15-30 minutes after administration of MGd, with continued tumor visibility at 2-4 hours. Examination with confocal microscopy allowed confirmation that the fluorescence of optical images and MR imaging T1 enhancement exclusively originated from MGd that accumulated in the cytoplasm of tumor cells.CONCLUSIONMGd-enhanced optical and MR imaging can allow determination of glioma tumor margins at the optimal time of 15-120 minutes after administration of MGd. Clinical application of these results may allow complete removal of gliomas in a hybrid surgical setting in which intraoperative optical and MR imaging are available.

In Vivo MR Spectroscopy Characteristics of Rat C6 Glioma Model and Its Histology Apperance

Characteristics of MR Spectroscopy in Peritumoral Zone of Astrocytic Tumors

Preliminary Study of MR Perfusion Imaging for C6 Brain Glioma in Rats

Significance of MR Spectroscopy in the Classification of Intracranial Astrocytic Tumors

Characteristics of Rat C6 Glioma Model on 7T Animal MRI

Application of MR Spectroscopy in the Classification of Intracranial Astrocytic Tumors

Characteristics of Multivoxel Proton MR Spectroscopy in Brain Tumors:Comparison of Histological Pathology

Prognostic Factor from MR Spectroscopy in Rat with Astrocytic Tumour During Radiation Therapy.

1H Magnetic Resonance Spectroscopy (1H MRS) in the Initially Differentiating Recurrent Brain Gliomas after Radiation Therapy from Delayed Cerebral Necrosis

In Vivo Hydrogen-1 Magnetic Resonance Spectroscopy Study of Human Intracranial Tumors.

Study of 1H-Magnetic Resonance Spectroscopy in the Peritumoral Edema of Astrocytomas in Brain

Integrative Magnetic Resonance Imaging and Metabolomic Characterization of a Glioblastoma Rat Model

Clinical Value of MR Spectroscopy in Preoperative Grading of Astrocytic Tumors

Noninvasive Delineation of Glioma Infiltration with Combined 7T Chemical Exchange Saturation Transfer Imaging and MR Spectroscopy: A Diagnostic Accuracy Study

Diagnosis of brain tumors with multiple-voxel proton MR spectroscopy

Magnetic Resonance Spectroscopic and Perfusion MRI in High Grade Gliomas and Metastases

Compared Study of Hippocampus Pathological Lesion with Magnetic Resonance Spectroscopy in Experimental Cerebral Ischemic Rats

Gliomas findings on proton magnetic resonane spectroscopy imaging and its clinical application

Gliomas: Motexafin Gadolinium-enhanced Molecular MR Imaging and Optical Imaging for Potential Intraoperative Delineation of Tumor Margins.

1H-MR spectroscopy in grading of cerebral glioma: A new view point, MRS image quality assessment

Application Of Magnetic Resonance Spectroscopy In The Preoperative Grading Of Gliomas